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Sheep is a relevant large animal model that is frequently used to test innovative tissue
engineering (TE) approaches especially for bone reconstruction. Mesenchymal stem
cells (MSCs) are used inTEapplicationsbecause they represent key componentof adult
tissue repair. Importantly, MSCs from different species show similar characteristics,
which facilitated their application in translational studies using animal models.
Nowadays, many researches are focusing on the use of ovine mesenchymal stem cells
(oMSCs) in orthopedic preclinical settings for regenerative medicine purposes.
Therefore, there is a need to amplify our knowledge on the mechanisms underlying
the behaviour of these cells. Recently, several studies have shown thatMSC function is
largely dependent on factors that MSCs release in the environment, as well as, in
conditionedmedium (CM). It has been demonstrated thatMSCs through autocrine and
paracrine signals are able to stimulate proliferation, migration, and differentiation of
different type of cells including themselves. In this study,we investigated the effects of
the CM produced by oMSCs on oMSCs themselves and we explored the signal
pathways involved.Weobserved thatCMcaused an enhancement of oMSCmigration.
Furthermore,we found thatCM increased levels of twomembraneproteins involved in
cell migration, Aquaporin 1 (AQP1), and C-X-C chemokine receptor type 4 (CXCR4),
and activated Akt and Erk intracellular signal pathways. In conclusion, taken together
our results suggest the highpotential of autologousCMas apromising tool tomodulate
behaviour of MSCs thus improving their use in therapeutically approaches.
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1 | INTRODUCTION
Mesenchymal stem cells (MSCs) represent an optimal tool for tissue
regeneration in a clinical setting due to their multipotency, being able
to differentiate into various cells (bone, cartilage, fat, muscle, and
tendon) under appropriate conditions. This particular property
together with their low immunogenicity and the ability to secrete
bioactive factors (cytokines, chemokines, and growth factors) in
response to local microenvironmental cues, makes them an ideal
candidate for the treatment of different pathologies (Dalal, Gandy, &
Domen, 2012; Gnecchi, Danieli, & Cervio, 2012; Liu, Shu, Kenny,
Chang, & Leung, 2014; Park, Kim, Lee, Park, & An, 2015).Antonella Zannetti and Arturo Brunetti contributed equally to this work.
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In particular, MSCs can migrate toward the injured tissues in
response to different factors and here they can secrete molecules
involved in the repair of damage. These secreted factors can be found
in the medium where MSCs are cultured; thus, the medium is called
conditioned medium (CM) (Pawitan, 2014). The CM, regulating
multiple physiologic functions, must be taken into due consideration
in therapy for several advantages (rapid collection, freeze-dried,
packaged, and transported more easily) compared to the use of MSCs
(Angoulvant et al., 2011; Huang et al., 2015). Furthermore, the use of
CM could overcome rejection problems linked to the compatibility
between the donor and the recipient.
The improvement of several MSCs-based therapies, as well as, the
development of new strategies for measuring the efficacy of MSCs in
preclinical studies, has increasingly required the use of large animal
models (Cibelli et al., 2013). Notably, these animal species can provide
significant advantages when modelling specific human disease
conditions and testing stem cell therapies (Harding, Roberts, &
Mirochnitchenko, 2013).
Among the large animals, sheep are an ideal model for bone tissue
engineering (Guo et al., 2004; Pobloth et al., 2016; Sanjurjo-Rodríguez
et al., 2017) and have been proposed for awide range of applications in
biomedical research (Adamzyk et al., 2016; Delling, Brehma, Ludewigb,
Winterc, & Jülkec, 2015; Scheerlinck, Snibson, Bowles, & Sutton, 2008;
Sill et al., 2011). Sheep are used to test the efficacy ofMSCs in different
bone's pathologies because evidence proves that their skeletal
structure has a higher resemblance to the human one as compared
to mice and rabbits (Kalaszczynska et al., 2013; O’Loughlin et al., 2008;
Pearce, Richards, Milz, Schneider, & Pearce, 2007; Petite et al., 2000).
Despite a considerable number of reports employing ovine MSCs
(oMSCs) in tissue engineering (Al Faqeh, Nor Hamdan, Chen,
Aminuddin, & Ruszymah, 2012; Boos et al., 2011; Di Bella et al.,
2010; Dozza et al., 2017; Lucarelli et al., 2005; Mrugala et al., 2008;
Scharf et al., 2015), thereare limited studiesregarding their morpho-
logical and biochemical characterization (Burk et al., 2017; Desantis
et al., 2015; Lyahyai et al., 2012, McCarty, Gronthos, Zannettino,
Foster, & Xian, 2009; Mrozik et al., 2010; Rentsch et al., 2010;
Zannettino, Paton, Itescu, & Gronthos, 2010). Differently from human
MSCs, oMSCs are not well studied for their physiological activity and
behaviour in tissue repair.
It is well known that regulation of MSCs migration is a complex
phenomenon that requires the contribution of numerous regulatory
factors. Stromal cell-derived factor (SDF) and its receptor C-X-C
chemokine receptor type 4 (CXCR-4) certainly represent an important
pathway involved in mediating cell migration. Recently, we demon-
strated the ability of conditioned medium (CM) from human bone-
marrow mesenchymal stem cells (hBM-MSCs) to promote migration
and invasion of osteosarcoma and hepatocellular carcinoma cells
through CXCR4 signalling (Fontanella et al., 2016). In addition, it has
been demonstrated that the overexpression of CXCR4 accelerates
MSCs mobilization in the infarcted myocardium (Zhang et al., 2008).
Many studies report that aquaporins (AQPs), a family of 13 water-
transporting membrane channel proteins known for their key role in
fluid transport in various tissues (Verkman, 2005) play a crucial role in
different biological processes related to cell migration (Papadopoulos,
Saadoun, & Verkman, 2008), proliferation, apoptosis, and cell volume
regulation (Conner et al., 2012). Importantly, it has been observed that
AQP1 promotes MSC migration in physiological and pathological
conditions (Meng et al., 2014; Pelagalli, Nardelli, Fontanella, &
Zannetti, 2016). The aim of this study was to evaluate whether CM
produced by ovine MSCs (oMSCs) could affect, through autocrine
signals, their capacity to migrate and proliferate. Furthermore, we
investigated the possible involvement of AQP1 and CXCR4, as well as,
the activation of downstream signals such as PI3K/Akt andMAPK/Erk
pathways in mediating CM effects on oMSCs.
2 | MATERIALS AND METHODS
2.1 | Isolation, culture, and immunophenotypic
characterization of ovine bone-marrow mesenchymal
stem cells (oMSCs)
Ovine bonemarrow aspirates were obtained according to the isolation
protocol previous described by Dozza et al. (2011). In particular,
heparinized aspirates were obtained from iliac crests of five 18–24
month sheep at Rizzoli Orthopaedic Institute. Isolation and culture
expansion of ovine bone marrow mesenchymal stem cell (oMSCs) was
performed as previously described (Dozza et al., 2011) through
gradient separation and plastic adherence. Ovine MSCs were
characterized using FC500 flow cytometer (Beckman Coulter, Brea,
CA) for staminal markers and they resulted positive for CD44, CD73,
CD90, CD105, CD146, and negative for CD34 and CD45 (Beckman
Coulter, Fullerton, CA). The MSC-enriched interface fraction was
collected and plated in a 10 cm dish containing culture medium (a-
MEM; Sigma Chemical, St. Louis, MO) with 10% FBS and 1% v/v
penicillin/streptomycin/fungizone (PSF). The medium was changed
every 4 days. When the cells reached 80% confluence, they were
trypsinized and passaged into new 10 cm dishes at a cell density at
5 × 105 cells/dish. According to themethodwell described fromDozza
et al. (2011), ovine MSCs were sub-cultured until P3 (passage 3). P3
cells were then seeded at designated condition and subjected to
experiments, and the remaining cells were stored for later use. The
isolated and characterized ovine MSCs, were grown in medium with
10% FBS.
2.2 | Preparation of oMSCs conditioned medium
Conditionedmedium (CM)was obtained fromoMSCs (passage 2 and at
80–90% confluency) grown for 24 hr in mediumwith 1% FBS. CMwas
collected, centrifuged at 1000g for 5 min to remove debris, filtered,
and stored in aliquots at −80 °C.
2.3 | Western blot analysis
In order to evaluate protein expression, oMSCs were cultured for 24 hr
with medium supplemented with 1% FBS, 10 % FBS, or in presence of
CM.Western blot analysis was carried out, as described previouslywith
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some modifications (Zannetti et al., 2008, 2012). Whole-cell lysates
were prepared by homogenization in lysis buffer (40mMHepes, pH7.5,
120mMNaCl, 5mMMgCl2, 1mM EGTA, 0,5mM EDTA, 1% Triton X-
100) with protease inhibitors cocktail (complete tablets-EDTA free,
Roche, Basel, Switzerland) and phosphatase inhibitors (20mM α-
glycerol-3-phosphate, 2,5mM Na-pyrophosphate). Protein concentra-
tion was determined by the Bio-Rad DC protein assay (Bio-Rad,
Hercules, CA). Equal proteins samples (50 μg) were loaded and
separated by on NUPAGE 4-12% Bis-Tris gels (Invitrogen, Carlsbad,
CA) using MES-SDS running buffer. Then, proteins were transferred to
nitrocellulose membrane using the iBlot gel transfer System Invitrogen
for immnuoblot. After blocking with 5% not fat milk powder in Tris-
buffered saline 0.1% Tween 20, the membranes were incubated
overnight at 4 °C with primary antibodies: anti-AQP1 (rabbit polyclonal
orb10122 Biorbyt, dilution 1:500) and anti-CXCR4 (rabbit polyclonal
IMG-537 Imgenex, San Diego, CA, dilution 1:500).
To investigate the intracellular signal pathways activated by CM in
oMSCs, the levels of Akt/p-Akt, Erk/p-Erk, and FAK/p-FAK were also
evaluated. The antibodies used were: rabbit polyclonal anti-Akt (CST-
9272, Cell Signaling, Leiden, the Netherlands), rabbit polyclonal anti p-
Akt (Ser473) (CST-9271, Cell Signaling), rabbit polyclonal anti-Erk
(CST-9102, Cell Signaling), rabbit polyclonal anti p-Erk (CST-9101, Cell
Signaling), rabbit polyclonal anti-FAK (Cell Signaling, 3285), rabbit anti
p-FAK (Y397) (pFAK, Cell Signaling, 3283), and mouse anti-β-actin
(A4700, Sigma–Aldrich Corp, St Louis, MO).
After rinsing with TBS-T, the membranes were incubated with
HRP-conjugated secondary anti-rabbit and anti-mouse antibodies
(mouse: 115-035-003, rabbit 111-005-003 Jackson ImmunoResearch,
Baltimore, PA, dilution 1:2000) for 1 hr at room temperature. To
visualize the immunoreactive proteins bands, an ECL detection kit
(Advansta, Menlo Park, CA) was used. Band acquisition was performed
by using the C-Digit Blot Scanner (Li-Cor). The level of expression of
different proteins was analyzed by using the public domain software
ImageJ (a Java-based image processing tool inspired by National
Institutes of Health's Image for windows).
2.4 | Transwell migration assay
Cell migration assay was performed using 24-well Transwell chambers
(Corning, Inc., Corning, NY) containing inserts with an 8 μm
polycarbonate pore membrane. Briefly, oMSCs were placed in the
upper chamber (2.5 × 105 cells/well) in serum free α-MEM. Medium
containing 1% FBS, 10% FBS, and CM were added to the lower
chamber as chemoattractants. After incubation in a humidified
incubator with 5% C02 at 37 °C for 24 hr, oMSCs that had not
migrated through the filter were removed using a cotton wool swab.
Migration of cells to the lower surface of the membrane insert was
evaluated by staining with 0.05% crystal violet in 25% methanol and
imaged under a microscope. Stained cells were extracted by eluting
crystal violet with 1% sodium dodecyl sulphate and reading the
absorbance at 595 nm by a Thermo Scientific Multiskan, Thermo
Scientific, Helsinki, Finland, FC microplate reader. For each migration
assay three identical replicate were performed. To block AQP1 and
CXCR4 the cells were incubated with 100 μM of tetraethylammonium
chloride (TEA) (Müller, Hub, Grubmüller, & de Groot, 2008) and
AMD3100 (10 μM), respectively.
2.5 | Wound healing assay
The wound healing assay was performed as previously described
(Pelagalli et al., 2016). Briefly, oMSCswere seeded into six-well dishes at
a density of 1 × 105 cells/well and grown until confluent. To these
monolayers a linear woundwas gently created using a sterile pipette tip
(200 μl). Then, each well was washed with medium to remove cell
detached. Wounded cell cultures were then incubated for 24–48 hr in
the presence of medium supplemented with 1% FBS, 10% FBS, or
oMSC-CM. Themigration of cells to close thewoundwas observed and
images captured at different time points (0, 24, and 48 hr) using a phase
contrastmicroscopy (Leica) equippedwith a digital camera (Canon). The
surface areas of the cell-free zones were measured and the percentage
scratch closure was quantified with TScratch software (Gebak, Schulz,
Koumoutsakos, & Detmar, 2009). Results are expressed as the
percentage of wound closure at 24 hr and 48 hr respect to time 0.
2.6 | Statistical analysis
Data are reported as themean ± standard deviation (SD). The Student's
t-test was used for comparison of the mean values between different
groups. All p-values were two-tailed, and *p < 0.05 was considered
statistically significant.
3 | RESULTS
3.1 | Expression of AQP1 and CXCR4 in oMSCs
In order to assess the autocrine effect of CM on oMSCs, these cells
were cultured in presence ofmedium supplementedwith 1%FBS, 10%
FBS, or CM for 24 hr and the levels of AQP1 and CXCR4, were
analysed. As shown in Figure 1a, oMSCs express both AQP1 and
CXCR4 proteins and their levels are increased when cells were grown
in presence of 10%FBS or in presence of CM respect to 1%FBS. These
results are confirmed by densitometric analysis of AQP1 and CXCR4
bands normalized for beta actin used as a protein loading control
(Figure 1b). Interestingly, the effect of CM caused a 1.8 and 1.63 folds
increase of AQP1 and CXCR4 levels, respectively, in comparison with
the control (1% FBS), thus confirming the autocrine signal of CM.
3.2 | Intracellular signaling pathways activated by
CM in oMSCs
To elucidate the mechanism underlying of CM effect on oMSCs we
analysed AQP1 and CXCR4 downstream signaling. We investigated
the involvement of intracellular pathways such as the phosphatidyl-3-
kinase (PI3K)/Akt and extracellular signal-regulated kinase 1/2 (Erk1/
2) (Hayashi, Tsuchiya, Nakayama, Takayuki, & Nishida, 2008). We
found that CM increased phosphorylation either Akt and Erk in oMCSs
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compared to that observed in cells grown in medium supplemented
with 1% FBS (control), whereas no increase was observed in Akt and
Erk levels (Figure 2a). In particular, CM caused an higher increase of
pAkt/total Akt and pErk/total Erk protein ratio (130 ± 8.34;
162 ± 8.03), respectively, respect to 1% FBS (considered as 100%)
(Figure 2b). The induction of pAkt and pErk caused by CM was also
higher than that elicited by medium supplemented with 10% FBS
(121 ± 7.42; 125 ± 8.73, respectively). Furthermore, in accord with
other studies (Meng et al., 2014) that demonstrated the involvement of
AQP1 in human MSC migration through FAK pathway, we found that
CM caused an increase of FAK phosphorylation of 140 ± 8.54 respect
to control (1% FBS) (Figures 2a and 2b).
3.3 | Autocrine effect of CM on oMSC migration and
wound healing
It has been known that MSCs with high levels of AQP1 and/or CXCR4
show a strong ability to migrate to the site of injury and regulate the
repair process. To assess the CM effect on oMSCs migration a trans-
well chamber was used. As shown in Figures 3a and 3b, a significant
increase of cell migration was observed when oMSCs were exposed to
CM or medium supplemented with 10% FBS, added to the lower
chamber as chemoattractants. The cell migration to medium supple-
mented with 1% FBS was considered 100% and used as control
(*p < 0.001). The inhibition of CXCR4 using AMD3100 (10 μM) and of
AQP1 using TEA (100 μM) dramatically suppressed the migration of
oMSCs that was promoted by CM (#p < 0.05).
Furthermore, we observed that the treatment of oMSCs with CM
induced a significant enhancement in wound closure both at 24 hr and
48 hr compared to control (1% FBS) (49.3% ± 2.45 vs 35.33 ± 3.5 at
24 hr; 76.07% ± 3.07 vs 52.07 ± 3.06 at 48 hr) (*p < 0.001). Treatment
of cells with AQP1 inhibitor (TEA) or CXCR4 inhibitor (AMD3100)
caused a significant delay in wound closure compared to cells grown in
FIGURE 1 Expression of AQP1 and CXCR4 in oMSCs. (a)
Western blot analysis of AQP1 and CXCR4 expression in oMSC
grown for 24 hr in presence of 1% FBS, 10% FBS and oMSC-CM.
Equal loading was confirmed by immunoblot with β-actin antibody.
Molecular weights of indicated proteins are reported. Depicted
results represent one of three typical experiments performed; (b)
The histogram indicates the fold of densitometric signals, reported
as relative to 1% FBS, arbitrarily set to 1. Data are expressed as
mean ± SD from three independent experiments. *p < 0.01
FIGURE 2 Intracellular signalling pathways activated by CM in
oMSCs. (a) Representative Western blots of phosphorylated and
total Akt, Erk, and FAK in oMSCs grown for 24 hr in presence of 1%
FBS, 10%FBS, and oMSC-CM. Equal loading was confirmed by
immunoblot with β-actin antibody. Molecular weights of indicated
proteins are reported. Depicted results represent one of three
typical experiments performed. (b) The histogram indicates, pErk/
Erk, pAkt/Akt pFAK/FAK ratio of densitometric signals, reported as
relative to 1% FBS-treated cells, arbitrarily set to 100%. Results of
densitometric analysis of Akt, Erk, and FAK activation normalized to
β-actin, performed from three different Western blotting. Data are
expressed as mean ± SD from three independent experiments,
*p < 0.01
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the presence of CM alone (TEA: 33.07 ± 2.5 vs 49.3% ± 2.45 at 24 hr,
59.38 ± 2.51 vs 76.07% ± 3.07 at 48 hr; AMD3100: 26.02 ± 2.74 vs
49.3% ± 2.45 at 24 hr; 39.5 ± 3.26 vs 76.07% ± 3.07 at 48 hr. #p < 0.05)
(Figures 4a and 4b). Taken together, these results suggest the crucial
role played by AQP1 and CXCR4 in promoting oMSC migration.
4 | DISCUSSION
Nowadays, many studies are focused on paracrine effects elicited by
CM of the MSCs whereas the autocrine mechanism has not yet been
entirely elucidated.
Conditionedmedium formMSCs, containing a cocktail of different
factors (growth factors, cytokines, interleukins, and C-C ligands etc.),
represents a promising tool in regenerative medicine. The ability of
MSCs to repair damaged tissues depends on their migration attitude
needed to move from residing niches to injured tissues (Rennert,
Sorkin, Garg, & Gurtner, 2012). Migration and proliferation of MSCs
are controlled by complicated signal networks. For such purposes, a
good knowledge regarding MSC biochemical characterization is
necessary in order to better clarify their potential use in therapy.
Recently, numerous studies have been carried out on therapeutic
application of autologous oMSCs in models of injury of cartilage and
bone (McCarty et al., 2010). Furthermore, Chang et al. (2015) studied
the possible use of conditioned medium on endogenous stem cells to
enhance their ability to repair tissue injuries.
Here, we report for the first time that the autocrine loop of CM
produced from oMSCs on oMSCs themselves causes an enhancement
of migration, wound healing closure, as well as, expression of AQP1
and CXCR4 (Figure 5). Our results demonstrated an inhibitory effect of
oMSCmigration by TEAand byAMD3100. TEA is a specific inhibitor of
AQP1 permeability, has been recently studied to investigate its
involvement in proliferation andmigration of humanMSCs (Ding et al.,
2012; Pelagalli et al., 2016). AMD3100 is a well-known CXCR4
antagonist used to modulate the receptor activity in different
physiological and pathological states (Cashen, Nervi, & Di Persio,
2007; Fontanella et al., 2016).
Many researches focused their attention on the role of aquaporins
family on tumor cell migration (Jiang, 2009; Monzani, Shtil, & La Porta,
2007; Papadopoulos & Saadoun, 2015) and metastatic process (Hu &
Verkman, 2006). It has been hypothesized that these pore-channel
proteins might provide the major pathway for water entry into
FIGURE 3 Autocrine effect of oMSCS-CM on oMSC migration. (a) Representative images of oMSCs migration in response to 1% FBS, 10%
FBS, and CM, used as chemoattractants analysed using transwell assay. (b) The cell migration to medium supplemented with 1% FBS was
considered 100% and used as control (*p < 0.001). The effects on oMSC migration of CXCR4 inhibitor, AMD3100 (10 μM) and of AQP1
inhibitor, TEA (100 μM) are evaluated respect to CM (#p < 0.05)
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FIGURE 4 Autocrine effect of oMSCS-CM on oMSC wound healing. (a) Representative images of oMSC scratch wounds after cells were
grown for 24 and 48 hr in medium containing 1% FBS or 10% FBS or oMSCS-CM in the presence of the CXCR4 inhibitor AMD3100 (10 µM)
or AQP1 inhibitor, TEA (100 μM). The images were captured using a digital camera attached to phase contrast microscopy. (b) The extent of
wound closure was quantified with TScratch software. Data are expressed as mean ± SD from three independent experiments. *p < 0.001
versus medium with 1% FBS; #p < 0.001 versus oMSC-CM
FIGURE 5 Schematic illustration of Ovine MSC-CM autocrine effect on oMSC behaviour and signal pathways involved
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lamellipodia (Verkman, 2005) driven by the local osmotic gradient
(Saadoun, Papadopoulos, Hara-Chikuma, & Verkman, 2005), whereas
Papadopoulos et al. (2008) reported that the AQP1 could act by
polarization facilitating water movements that mediate rapid changes
in cell volume.
CXCR4 represents a receptor of SDF-1α motif chemokine axis,
with a pivotal role for the migration and homing of multiple cell type to
specific tissues (Li, Luo, & Sun, 2015; Santagata et al., 2017). Mognetti,
La Montagna, Perrelli, Pagliaro, and Penna (2013) showed that among
the many factors produced in vitro by BM-MSCs, SDF1α is the main
modulator of cell migration. Many studies reported that CXCR4
activates several G-protein-mediated downstream signalling pathways
after its stimulation (Ganju et al., 1998; Kang et al., 2015) including
PI3K/Akt and MAPK network.
In accordance with our recent findings, in this study we observed
an enhancement of phosphorylated forms of Akt and Erk correlated
withMSCmigration (Camorani et al., 2017). Furthermore, we detected
also a p-FAK increase in oMSC stimulated by CM, similar findings were
reported by Meng et al. (2014) that showed the ability of AQP1 to
modulate MSC migration mainly through the FAK pathway.
However, further studies will be needed to clarify the autocrine
activity of oMSC-CM, as well as, to characterize completely its
composition.
In conclusion, our findings suggest CM as possible autocrine
modulator of MSC behaviour in tissue repair and regeneration.
Importantly, theuseofCMcouldbring several advantages inorthopaedic
field including cost effectiveness, efficiency and low invasiveness.
Furthermore, this study corroborates the importance of mesenchymal
stemcell-derived secretomeandmicrovescicles as a cell-free therapeutic
that can overcome the listed pitfalls related to cell-based therapeutics
(Hill, Pelagalli, Passaro, & Zannetti, 2017; Kim, Choi, & Kim, 2013).
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